Iadademstat + SBRT With Atezo in ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Atezolizumab
Related studies linked through entity extraction aliases.
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver Transplant
- Status
- RECRUITING
- Phase
- PHASE4
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
The Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma (HCC)
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study on the Efficacy of Atezolizumab Combined with Chemotherapy
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I/Ib Trial of TIraGolumab, AtEzolizumab, and RadScopal Radiation in Patients With Advanced Solid Malignancies (TIGER)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
- Status
- RECRUITING
- Phase
- PHASE3
Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3